Elderly frailty may change how muscle relaxants work during surgery
NCT ID NCT07580144
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times
Summary
This observational study looks at whether sarcopenia (muscle loss) and frailty affect how the muscle relaxant rocuronium works in older patients having surgery. Researchers will monitor 100 adults aged 65 and older to see how fast the drug takes effect and how long it lasts. The goal is to help doctors give safer anesthesia doses to frail elderly patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rocuronium
- What this could lead to
- If successful, this could help anesthesiologists adjust rocuronium doses for frail or sarcopenic elderly patients, improving safety during surgery.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures effects without testing a new drug or intervention, so direct patient benefits are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAILTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Betul Kozanhan
Konya, 42005, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart sensors at home could spot frailty early and lend a helping hand
- Could muscle loss predict stroke recovery?
- Can nerve changes explain Age-Related muscle loss?
- Can a simple skin scrub sharpen surgical monitoring?
- Muscle loss in aging: can diet and exercise turn back the clock?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?